Latest news, press releases, and SEC filings for Galapagos NV (GLPGF) https://caymanjournal.com/stock/GLPGF en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:29:01 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🔥 What This Document Is This is a **6-K report** from Galapagos NV, a Belgian biotech company listed on Euronext and NASDAQ (ticker: GLPG). It’s a current report used to announce major events to investors. This specific filing announces a new, binding collaboration deal with pharmaceutical giant https://caymanjournal.com/stock/GLPGF/sec-filing/0001193125-26-132908 https://caymanjournal.com/stock/GLPGF/sec-filing/0001193125-26-132908 Tue, 31 Mar 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **6-K filing** from Galapagos NV, a Belgian biotech company. It's a "current report" filed with the SEC to inform investors of major events. This specific filing announces that Galapagos has published its **2025 Annual Report** and is calling two shareholder meet https://caymanjournal.com/stock/GLPGF/sec-filing/0001193125-26-130447 https://caymanjournal.com/stock/GLPGF/sec-filing/0001193125-26-130447 Mon, 30 Mar 2026 00:00:00 GMT SEC Filing